SXLV:SW:SW-SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 44.675

Change

+0.34 (+0.76)%

Market Cap

N/A

Volume

24.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
RGLDS:SW Raiffeisen ETF Solid Gold A US..

-13.00 (-0.18%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+33.50 (+0.70%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+14.40 (+0.96%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+3.50 (+0.17%)

USD 134,034.85B
SX7EEX:SW iShares EURO STOXX Banks 30-15..

+0.04 (+0.31%)

USD 6,289.31B
TDXPEX:SW iShares TecDAX® UCITS ETF (DE..

+0.35 (+1.18%)

USD 5,933.97B
SMIEX:SW iShares SLI UCITS ETF (DE)

+1.10 (+0.86%)

USD 5,933.96B
DJSXE:SW iShares Core EURO STOXX 50 UCI..

N/A

USD 5,933.96B
DAXEX:SW iShares Core DAX® UCITS ETF (..

+0.92 (+0.63%)

USD 5,933.93B
MDAXEX:SW iShares MDAX® UCITS ETF (DE) ..

+0.05 (+0.02%)

USD 5,933.92B

ETFs Containing SXLV:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.65% 60% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.65% 60% D- 61% D-
Trailing 12 Months  
Capital Gain 17.49% 68% D+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.49% 68% D+ 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.89% 58% F 57% F
Dividend Return 1.89% 58% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.62% 53% F 59% D-
Risk Adjusted Return 40.82% 54% F 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike